Panel Discussion: ALS Clinical Trials & Access to Investigational Therapies Through Expanded Access Programs: Perspectives from Patients, Caregivers, Advocacy & Biopharma, & How the Path to Diagnosis Shapes These Decisions
Time: 3:30 pm
day: Conference Day Two PM
Details:
- Exploring the path to receiving an ALS Diagnosis
- Highlighting the importance of early and meaningful patient involvement in shaping trial goals, eligibility criteria and logistics to ensure trials reflect patient priorities
- Unpacking the decision to participate in a clinical trial
- Balancing patient centricity and science in developing clinical trial protocols
- Discussing how to gather actionable insights from patients and PAGs to ensure input drives meaningful changes in trial processes
- Examining strategies to make trials more accessible to patients including geographical, financial and logistical barriers, while fostering open communication between researchers and participants
- Reshaping EAPs and OLEs with community-driven recommendations to ensure they meet the needs of patients and caregivers while advancing ALS research
- Highlighting how caregiver roles and patient input can shape policies to improve trial participation rates and strengthen trust within the ALS community
